Dr. Nathalie Renee Seoldo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Tsaile Health Center, Route 64 & 12, Tsaile, AZ 86556 Phone: 928-724-3645 Fax: 928-724-3605 |
Clarissa Miller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Tsaile Medical Center Indian Rte 64, Tsaile, AZ 86556 Phone: 928-724-3600 |
Julie Elizabeth Dunston, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Junction Hwy 12 And 64, Tsaile, AZ 86556 Phone: 928-724-6001 |
Sergey Selinger Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Route 64 And 12, Tsaile, AZ 86556 Phone: 928-724-3643 |
Dr. Lindsay Campbell, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Navajo Route 64 & 12, Tsaile, AZ 86556 Phone: 928-724-3643 |
Mr. Terry Lee Teller, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Navajo Route 64 And 12, Tsaile Health Center, Tsaile, AZ 86556 Phone: 928-724-3644 Fax: 928-724-3605 |
News Archive
A drug proven effective for treatment of adults and children with sickle cell anemia reduced hospitalizations and cut annual estimated medical costs by 21 percent for affected infants and toddlers, according to an analysis led by St. Jude Children's Research Hospital. The report appears today in the advance online edition of the journal Pediatrics.
People with lower socioeconomic status and those belonging to ethnic minority groups receive worse health care in the treatment of diabetes than the rest of patients in the world's most developed countries.
As managed-care giant Kaiser Permanente assumes a prominent role in California's new covid-19 vaccination strategy, it is drawing mixed reviews from members across the country for the way it has run its own vaccine program over the past two months.
Eli Lilly and Company and Transition Therapeutics Inc. has announced that the two companies have entered into a licensing and collaboration agreement granting Lilly exclusive worldwide rights to develop and commercialize Transition's gastrin based therapies, including the lead compound TT-223, which is currently in early Phase II testing.
The doctoral dissertation focuses on school factors that affect the subjective wellbeing of school-aged children and how art can contribute to the wellbeing of students.
› Verified 4 days ago